Research on the genome of the virus that causes severe acute respiratory syndrome (SARS) has revealed an unusual molecular structure that looks like a promising target for antiviral drugs. A team of ...
Now that kids ages 5 to 11 are eligible for COVID-19 vaccination and the number of fully vaccinated people in the U.S. is rising, many people may be wondering what the endgame is for COVID-19. Early ...
Using human brain organoids, an international team of researchers, led by scientists at University of California San Diego School of Medicine and Sanford Consortium, has shown how the SARS-CoV-2 virus ...
The global SARS outbreak lasted from late 2002 to mid-2003. During this time, over 8,000 people contracted the virus and 774 people died. The origin of SARS-CoV is thought to be bats. It’s believed ...
After a period of falling Covid-19 illness rates, the recent spread of the delta variant of SARS-CoV-2 was a major disappointment and necessitated a reexamination of some previous assumptions. This ...
Chinese researchers said Thursday they had found a batch of new coronaviruses in bats including one that may be the second-closest yet, genetically, to the Covid-19 virus. According to the researchers ...
A prototype drug created by researchers at the University of Illinois at Chicago shows promise in slowing replication of the virus responsible for severe acute respiratory syndrome, or SARS. Currently ...
The frightening respiratory disease SARS, which paralyzed much of Asia in the spring of 2003, has since faded from the headlines, obscured by rising new threats like avian influenza. But scientists ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results